PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.
Zhang Z, Wang Z, Huang K, Liu Y, Wei C, Zhou J, Zhang W, Wang Q, Liang H, Zhang A, Wang G, Zhen Y, Han L.
Zhang Z, et al. Among authors: wang g, wang z, wang q.
Cancer Lett. 2019 Feb 28;443:91-107. doi: 10.1016/j.canlet.2018.11.034. Epub 2018 Dec 4.
Cancer Lett. 2019.
PMID: 30529153